Client
- Name
- NOVARTIS
- Location
- District of Columbia · United States of America
Registrant
- Firm
- NOVARTIS
- Description
- Federal Government Relations/Legislative Affairs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
7 issuesBudget/Appropriations
2025 Appropriations Funding for FDA - FY 2025 Appropriations FY 2025 President's Budget Request Inflation Reduction Act of 2022 (P.L. 117-169) 2025 LHHS
LobbyistsLEO A FARBER · JOSEPH MCGOWAN · TAYLOR BOOTH · COURTNEY LEE-ASHLEY · COURTNEY PIRON · SARAH DURR
TargetedSENATE · HOUSE OF REPRESENTATIVES · Congressional Budget Office (CBO) · Executive Office of the President (EOP) · White House Office · Office of Management & Budget (OMB)
Copyright/Patent/Trademark
Antitrust Legislation Artificial Intelligence (AI) Bayh-Dole Act March-In Rights Compulsory Licensing - 28 USC 1948 Government Use of Patents Coronavirus (COVID-19) Pandemic - TRIPS Waiver S.79/H.R. 1717: Interagency Patent Coordination and Improvement Act of 2023 S. 113: Prescription Pricing for the People Act of 2023 S. 148 Stop STALLING Act S. 150: Affordable Prescriptions for Patients Act of 2023 Restrictions on Intellectual Property Rights S. 2220/H.R. 4370: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act Patent Litigation Reform Patenting of Biological Inventions - Section 101 Modernization H.R. 6684: Improving Efficiency to Increase Competition Act - Patent-related policy issues
LobbyistsLEO A FARBER · JOSEPH MCGOWAN · TAYLOR BOOTH · COURTNEY LEE-ASHLEY · COURTNEY PIRON · SARAH DURR
TargetedSENATE · HOUSE OF REPRESENTATIVES · U.S. Trade Representative (USTR) · Commerce, Dept of (DOC) · Patent & Trademark Office (PTO)